Faropenem Dosing in Children
The recommended faropenem dosing in children is 15 mg/kg/day divided into three doses (5 mg/kg per dose three times daily), with a maximum of 30 mg/kg/day for more severe infections. 1, 2
Standard Dosing Regimen
Dose per kilogram:
- Standard dose: 15 mg/kg/day divided into 3 doses (5 mg/kg per dose)
- Higher dose range: Up to 30 mg/kg/day divided into 3 doses for severe infections 2
Dosing interval:
Treatment duration:
- 3-8 days for most infections
- 5-14 days for Group A streptococcal infections 2
Approved Indications in Pediatrics
Faropenem oral dry syrup is approved for treating:
- Upper respiratory tract infections (pharyngitis, tonsillitis)
- Acute bronchitis
- Otitis media
- Urinary tract infections
- Dermatological infections
- Bacterial periodontal infections 1, 2
Clinical Efficacy Data
In clinical studies, faropenem demonstrated:
- 90% efficacy in upper respiratory tract infections (63/70 cases)
- 94.1% efficacy in otitis media (16/17 cases)
- 100% efficacy in urinary tract infections (6/6 cases)
- 85.7% efficacy in acute bronchitis (6/7 cases) 2
The drug showed particularly potent activity against penicillin-resistant Streptococcus pneumoniae (PRSP), with high bacteriological eradication rates 2.
Special Populations
Disseminated tuberculosis (investigational use):
- Faropenem medoxomil: 30 mg/kg administered 3-4 times daily in combination therapy
- Target: >60% time above MIC 3
Renal impairment: While specific pediatric renal dosing adjustments are not explicitly provided in the available evidence, faropenem is a β-lactam antibiotic that requires renal dose adjustment in adults with significant renal dysfunction. Monitor renal function and consider dose reduction in children with creatinine clearance <30 mL/min/1.73m², though specific pediatric guidelines are not established.
Safety Profile
Common adverse effects:
- Diarrhea: 12.5% incidence (14/112 cases) 2
- No serious adverse drug reactions reported in pediatric studies
- Incidence of diarrhea comparable to other oral β-lactam antibiotics 2
Compliance: Patient compliance was reported as "very good" in clinical studies, likely due to the palatability of the dry syrup formulation and three-times-daily dosing 2.
Clinical Considerations
Advantages over other β-lactams:
- Stable against β-lactamases, including extended-spectrum β-lactamases
- Low propensity for bacterial resistance
- Broad spectrum of activity against both aerobic and anaerobic bacteria
- Oral formulation provides alternative to parenteral carbapenems 1
Formulation: Available as oral dry syrup for pediatric use, making administration easier in young children who cannot swallow tablets 1, 2
Important Caveats
- Faropenem is not approved in all countries; availability varies by region 1
- The drug should be administered three times daily for optimal efficacy, which requires adherence to the dosing schedule
- While faropenem has activity against resistant organisms, it should not be used as monotherapy for tuberculosis based on whole-blood bactericidal activity data 4